Form 4 for CUE Cue Biopharma, Inc.
Accepted 2021-10-08 00:00:00 ET · period of report 2021-09-30 · accession 0001209191-21-060022 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-08 | 2021-09-30 | CUE | PASSERI DANIEL R | CEO, Dir | F - Tax | $14.57 | -31.7K | 98.7K | -24% | -$461.5K |
| D | 2021-10-08 | 2021-09-30 | CUE | PASSERI DANIEL R | CEO, Dir | M - OptEx | — | +75.0K | 130.4K | +135% | — |
| D | 2021-10-08 | 2021-09-30 | CUE | PASSERI DANIEL R | CEO, Dir | M - OptEx | $0.00 | -75.0K | 75.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-30 | F | D | 31,677 | $14.57 | 98,700 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-30 | M | A | 75,000 | — | 130,377 | D | — | — | (F1) Represents shares of common stock received upon vesting of a restricted stock unit award. |
| 3 | Derivative | Restricted Stock Units | 2021-09-30 | M | D | 75,000 | $0.00 | 75,000 | D | — · — to — | 75,000 Common Stock | (F2) Each restricted stock unit award represents a contingent right to receive one share of common stock. (F3) One half of the Restricted Stock Units vested on September 30, 2021 and the balance will vest on March 31, 2022. |